Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 1294 entries
View as:

Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT01508858 Org: User:
Start: 11/30/06 End: 04/30/07 Due: 04/30/08

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00331851 Org: User:
Start: 05/31/06 End: 04/30/07 Due: 04/30/08

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process

Phase: N/A Priority: Normal
NCT ID: NCT01486914 Org: User:
Start: 01/19/03 End: 02/24/03 Due: 02/24/04

Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01082406 Org: User:
Start: 03/31/10 End: 07/31/10 Due: 07/31/11

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)

Phase: N/A Priority: Normal
NCT ID: NCT03876015 Org: User:
Start: 05/01/19 End: 08/12/20 Due: 08/12/21

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04582435 Org: User:
Start: 10/16/20 End: 04/22/22 Due: 04/22/23

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01819129 Org: User:
Start: 09/09/13 End: 01/22/15 Due: 01/22/16

A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05144984 Org: User:
Start: 11/29/21 End: 03/23/23 Due: 03/23/24

Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05533632 Org: User:
Start: 04/25/22 End: 01/18/24 Due: 01/18/25

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04083781 Org: User:
Start: 10/21/19 End: 02/21/27 Due: 02/21/28

A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)

Phase: N/A Priority: Normal
NCT ID: NCT03811535 Org: User:
Start: 05/20/19 End: 09/30/25 Due: 09/30/26

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00825253 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific

Phase: N/A Priority: Normal
NCT ID: NCT05250427 Org: User:
Start: 04/26/22 End: 05/23/22 Due: 05/23/23

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01508949 Org: User:
Start: 06/30/01 End: 03/31/02 Due: 03/31/03

O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait

Phase: N/A Priority: Normal
NCT ID: NCT05716724 Org: User:
Start: 01/25/23 End: 07/09/23 Due: 07/09/24

Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01572740 Org: User:
Start: 04/05/12 End: 03/27/13 Due: 03/27/14

A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

Phase: N/A Priority: Normal
NCT ID: NCT04058834 Org: User:
Start: 08/20/19 End: 04/23/20 Due: 04/23/21

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01620463 Org: User:
Start: 12/31/02 End: 03/31/03 Due: 03/31/04

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)

Phase: N/A Priority: Normal
NCT ID: NCT03631186 Org: User:
Start: 09/12/18 End: 12/18/19 Due: 12/18/20

Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01272232 Org: User:
Start: 06/01/11 End: 01/25/13 Due: 01/25/14

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00612040 Org: User:
Start: 01/31/08 End: 06/30/08 Due: 06/30/09

NovoLet® Acceptance Study Within the Hospital Practise in Indonesia

Phase: N/A Priority: Normal
NCT ID: NCT01492205 Org: User:
Start: 09/30/05 End: 06/30/06 Due: 06/30/07

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00318422 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01509755 Org: User:
Start: 10/31/00 End: 10/31/01 Due: 10/31/02

A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01569841 Org: User:
Start: 04/30/12 End: 11/30/12 Due: 11/30/13